BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31480231)

  • 1. Structural Insights into the Interaction of Cytochrome P450 3A4 with Suicide Substrates: Mibefradil, Azamulin and 6',7'-Dihydroxybergamottin.
    Sevrioukova IF
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5.
    Hsu MH; Johnson EF
    J Biol Chem; 2022 May; 298(5):101909. PubMed ID: 35398097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
    Chanteux H; Rosa M; Delatour C; Nicolaï J; Gillent E; Dell'Aiera S; Ungell AL
    Drug Metab Dispos; 2020 Sep; 48(9):778-787. PubMed ID: 32532738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
    Ohta T; Nagahashi M; Hosoi S; Tsukamoto S
    Bioorg Med Chem; 2002 Apr; 10(4):969-73. PubMed ID: 11836106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4.
    Zhou SF
    Curr Pharm Des; 2008; 14(10):990-1000. PubMed ID: 18473851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism.
    Sevrioukova IF; Poulos TL
    Curr Top Med Chem; 2014; 14(11):1348-55. PubMed ID: 24805065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding Specificity Determines the Cytochrome P450 3A4 Mediated Enantioselective Metabolism of Metconazole.
    Zhuang S; Zhang L; Zhan T; Lu L; Zhao L; Wang H; Morrone JA; Liu W; Zhou R
    J Phys Chem B; 2018 Jan; 122(3):1176-1184. PubMed ID: 29310431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.
    Ducharme J; Sevrioukova IF; Thibodeaux CJ; Auclair K
    Biochemistry; 2021 Jul; 60(28):2259-2271. PubMed ID: 34196520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction.
    Foti RS; Rock DA; Pearson JT; Wahlstrom JL; Wienkers LC
    Drug Metab Dispos; 2011 Jul; 39(7):1188-95. PubMed ID: 21447734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.
    Zhou SF
    Curr Drug Metab; 2008 May; 9(4):310-22. PubMed ID: 18473749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformations of 6',7'-dihydroxybergamottin and 6',7'-epoxybergamottin by the citrus-pathogenic fungi diminish cytochrome P450 3A4 inhibitory activity.
    Myung K; Manthey JA; Narciso JA
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2279-82. PubMed ID: 22342630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Human Drug-Metabolizing CYP3A4 with Small Inhibitory Molecules.
    Sevrioukova I
    Biochemistry; 2019 Feb; 58(7):930-939. PubMed ID: 30676743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
    Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Grapefruit Effect: Interaction between Cytochrome P450 and Coumarin Food Components, Bergamottin, Fraxidin and Osthole. X-ray Crystal Structure and DFT Studies.
    Rossi M; Aktar S; Davis M; Hefter Feuss E; Roman-Holba S; Wen K; Gahn C; Caruso F
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32664320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile applicability of a grid-based CYP3A4 Template to understand the interacting mechanisms with the small-size ligands; part 3 of CYP3A4 Template study.
    Yamazoe Y; Goto T; Tohkin M
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):253-265. PubMed ID: 32331852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
    Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
    Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.